Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON26307
NL-OMON26307
Not yet recruiting
Not Applicable

Dopaminergic neurotransmission and cognitive deterioration in velocardiofacial syndrome.

Governor Kremers Centre / Department of Clinical GeneticsMaastricht, the Netherlands0 sites44 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsvelocardiofacial syndromedel22q11.2dementiadementievelocardiofaciaal syndroom

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
velocardiofacial syndromedel22q11.2dementiadementievelocardiofaciaal syndroom
Sponsor
Governor Kremers Centre / Department of Clinical GeneticsMaastricht, the Netherlands
Enrollment
44
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Governor Kremers Centre / Department of Clinical GeneticsMaastricht, the Netherlands

Eligibility Criteria

Inclusion Criteria

  • •1\. Deletion 22q11\.2;
  • •2\. IQ \< 55\.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndrome - Dementia in VCFSDementia in velocardiofacial syndromeMedDRA version: 8.1Level: LLTClassification code 10012267Term: Dementia
EUCTR2006-006203-36-NLAcademic Medical Centre (AMC)
Completed
Not Applicable
Dopaminergic neurotransmission and cognitive deterioration in velocardiofacial syndrome
NL-OMON33641Medisch Universitair Ziekenhuis Maastricht44
Withdrawn
Not Applicable
Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndromecognitive declinedementia10083624
NL-OMON31666Academisch Medisch Centrum40
Recruiting
Not Applicable
Dopaminergic modulation of cognition and psychomotor functiogeen aandoeningnot applicable
NL-OMON38372niversiteit Maastricht30
Active, not recruiting
Not Applicable
Modulación dopaminérgica de las funciones cognitivas y afectivas por el tratamiento con diferentes métodos de estimulación dopaminérgica en la enfermedad de Parkinson . Implicaciones para el tratamiento con levodopa.Fluctuaciones motoras, cognitivas y del humor en la enfermedad de Parkinson.MedDRA version: 8.1Level: PTClassification code 10061536Term: Parkinson's disease
EUCTR2006-002408-32-ESInstitut de Recerca del Hospital de la Santa Creu i Sant Pau20